Calamos Advisors’s OrthoPediatrics KIDS Stock Holding History

Calamos Advisors’s Portfolio KIDS Stock Details KIDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-60,853	Closed	-$2.37M	–	776
2019 Q2	$2.37M	Buy	+60,853	New	+$2.45M	0.01%	602

Other funds holding KIDS

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Calamos Advisors's KIDS Position: Q3 2019 in Review

Calamos Advisors sold out of OrthoPediatrics (KIDS) in Q3 2019, closing a stake of 60,853 shares — an estimated $2.37M sold.

Calamos Advisors first reported a position in KIDS in Q2 2019 and held it in 1 quarter. The position peaked at $2.37M in Q2 2019. 90 funds tracked by Wall St. Rank hold KIDS as of Q3 2019.

Calamos Advisors reported no remaining OrthoPediatrics position as of Q3 2019 after selling out during the quarter.
Calamos Advisors sold 60,853 OrthoPediatrics shares in Q3 2019, an estimated $2.37M.
Calamos Advisors first reported a position in OrthoPediatrics in Q2 2019 and held it in 1 quarter.
Calamos Advisors's OrthoPediatrics position peaked at $2.37M in Q2 2019.
90 funds tracked by Wall St. Rank held OrthoPediatrics as of Q3 2019.

Based on Calamos Advisors's 13F filing for Q3 2019, filed 21 Oct 2019.